Table 1 Baseline Characteristics

Sex (Male)

40

67

Ethnic Origin (Caucasian)

59

98

Age (Years)

61 (median)

Stage

   M1A

10

17

   M1B

8

13

   M1C

42

70

Common Lesion Sites

   Lung

28

47

   Liver

28

47

   Lymph Nodes

23

38

   Subcutaneous

16

27

   Bone

13

22

   Spleen

3

5

   Adrenal Glands

3

5

Chemo- Naïve

11

18

Prior Chemo Exposure

49

82

Previous Systemic Treatments

   0

11

18

   1

18

30

   2

17

28

   3

9

15

   4

4

7

   5

1

2

Previous Adjuvant Therapy

   Dacarbazine/IL-2

16

27

   IFN

5

8

Previous Active Therapy

   Biochemotherapy

26

43

   High Dose IL-2

8

13

   Anti-CTLA4

7

12

   Temozolomide

7

12

   Vaccine

7

12